Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
455 On Other Exchanges
455 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

tianda pharmaceuticals ltd (455) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TIANDA PHARMACEUTICALS LTD (455)

Related News

No related news articles were found.

tianda pharmaceuticals ltd (455) Related Businessweek News

No Related Businessweek News Found

tianda pharmaceuticals ltd (455) Details

Tianda Pharmaceuticals Limited, an investment holding company, is engaged in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products. The company’s principal product consists of Cerebroprotein Hydrolysate Injection for craniocerebral trauma; to improve sequelae of cerebrovascular and improve deficiency of brain function; and that is conducive to those patients who lack protein or with neurasthenia. It offers cardio-cerebrovascular, pediatric, cold and respiratory system, anti-infective, and detoxification drugs, as well as complementary health care products, such as bone health, heart health, immune booster, nutritional oil, vitamin and mineral, women’s nutrition, well being, and personal care products. It operates in the People’s Republic of China, Hong Kong, and Australia. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. Tianda Pharmaceuticals Limited is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

456 Employees
Last Reported Date: 12/19/14

tianda pharmaceuticals ltd (455) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianda pharmaceuticals ltd (455) Key Developments

Tianda Pharmaceuticals Limited Appoints SHI Shaobin as Executive Director

Tianda Pharmaceuticals Limited announced that Mr. SHI Shaobin has been appointed as an executive Director of the company with effect from 13 March 2015. Mr. SHI currently acts as the chairman of Guangzhou Electronic Commerce Network.

Tianda Pharmaceuticals Limited Announces Unaudited Consolidated Cash Flow Results for the Six Months Ended September 30, 2014

Tianda Pharmaceuticals Limited announced unaudited consolidated cash flow results for the six months ended September 30, 2014. For the six months, the company announced net cash used in operating activities was HKD 13,434,482 compared to net cash generated from operating activities of HKD 34,848,906 for the same period a year ago.

Tianda Pharmaceuticals Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2014

Tianda Pharmaceuticals Limited announced unaudited consolidated earnings results for the six months ended September 30, 2014. For the six months, the company's revenue was HKD 66,462,426 compared with HKD 124,329,645 a year ago. Loss before tax was HKD 13,071,891 compared with profit before tax of HKD 39,806,424 a year ago. Loss profit for the period attributable to owners of the company was HKD 8,926,311 against profit of HKD 15,799,443 a year ago. Basic loss per share was 0.48 cents against profit of 0.84 cents a year ago. Additions to property, plant and equipment amounted to HKD 30,256,588 compared to HKD 3,064,335 reported a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
455:HK $0.42 HKD -0.005

455 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 455.
View Industry Companies

Industry Analysis


Industry Average

Valuation 455 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.1x
Price/Book 1.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANDA PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at